Avestar Capital’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.25M Buy
14,400
+1,300
+10% +$488K 0.29% 62
2026
Q1
$3.69M Buy
13,100
+1,200
+10% +$348K 0.24% 77
2025
Q4
$3.52M Buy
11,900
+2,200
+23% +$663K 0.23% 75
2025
Q3
$2.39M Buy
9,700
+400
+4% +$80.6K 0.16% 109
2025
Q2
$1.45M Sell
9,300
-4,300
-32% -$457K 0.1% 149
2025
Q1
$1.07M Buy
13,600
+12,100
+807% +$1.28M 0.09% 181
2024
Q4
$138K Buy
+1,500
New +$117K 0.01% 495
2024
Q3
Sell
-1,000
Closed -$57.3K 475
2024
Q2
$57.3K Buy
+1,000
New +$50.4K 0.01% 446

Other funds holding CLS

Avestar Capital's CLS Position: Q2 2026 in Review

Avestar Capital reduced its Celestica (CLS) stake by 33% in Q2 2026, selling an estimated $866K and leaving 4,667 shares worth $1.7M. The position accounts for 0.1% of the portfolio, ranked #158.

Avestar Capital first reported a position in CLS in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.96M in Q1 2026. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Avestar Capital held 4,667 shares of Celestica worth $1.7M as of Q2 2026.
  • Avestar Capital sold 2,308 Celestica shares in Q2 2026, an estimated $866K.
  • Celestica made up 0.1% of Avestar Capital's portfolio in Q2 2026, its #158 holding.
  • Avestar Capital first reported a position in Celestica in Q1 2024 and has held it in 10 quarters since.
  • Avestar Capital's Celestica position peaked at $1.96M in Q1 2026.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.